Ad26.COV2-S/Adalimumab/ElasomeranPapulopustular psoriasis

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 1999卷 / 1期

关键词：

D O I：

10.1007/s40278-024-54327-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：18 / 18

相关论文

共 50 条

[1] Ad26.cov2-s/tozinameranGuttate psoriasis: 2 case reports
Reactions Weekly, 2022, 1922 (1) : 25 - 25
[2] Ad26.COV2-S/elasomeran/tozinameranTransverse myelitis
Reactions Weekly, 2024, 2003 (1) : 26 - 26
[3] Ad26.COV2-S/tozinameranChronic spontaneous urticaria
Reactions Weekly, 2023, 1987 (1) : 16 - 16
[4] Ad26.cov2-s/elasomeranDRESS syndrome: case report
Reactions Weekly, 2022, 1927 (1) : 20 - 20
[5] Ad26.cov2-s/elasomeranDemyelinating neuropathy: 2 case reports
Reactions Weekly, 2022, 1917 (1) : 22 - 22
[6] Ad26.CoV2-S/heparinVarious toxicities: case report
Reactions Weekly, 2021, 1882 (1) : 23 - 23
[7] Ad26.cov2-s/tozinameranMyocarditis: 3 case reports
Reactions Weekly, 2022, 1918 (1) : 22 - 22
[8] Ad26.COV2-S/TozinameranDe novo immune thrombocytopenia
Reactions Weekly, 2024, 2002 (1) : 17 - 17
[9] Ad26.COV2-S/elasomeran/tozinameranVulval aphthous ulcers
Reactions Weekly, 2024, 2000 (1) : 16 - 16
[10] Ad26.cov2-s/elasomeranLack of efficacy:2 case reports
Reactions Weekly, 2023, 1942 (1) : 17 - 17

← 1 2 3 4 5 →